Dátum ex-dividendy spoločnosti AC Immune SA
Aká je hodnota metriky Dátum ex-dividendy spoločnosti AC Immune SA?
Hodnota metriky Dátum ex-dividendy spoločnosti AC Immune SA je N/A
Aká je definícia metriky Dátum ex-dividendy?
Dátum ex-dividendy (Ex-dividend date) je dátum, ktorý určuje či budú dividendy vyplatené predávajúcemu alebo kupujúcemu. Vyplatené dividendy za akcie kúpené po ex-dividend dátumom patria novému majiteľovi.
The ex-dividend date or reinvestment date is an investment term involving the timing of payment of dividends on stocks of corporations, income trusts, and other financial holdings. If a sale is before this date, the dividend belongs to the new owner; if on or after the date, the seller is entitled to the dividend. If a stock is purchased on its ex-dividend date or after, the buyer will not receive the next dividend payment. Instead, the seller gets the dividend. If a stock is purchased before the ex-dividend date, the buyer gets the dividend.
Čomu sa venuje spoločnosť AC Immune SA?
ac immune is a clinical-stage swiss-based biopharmaceutical company, listed on nasdaq, which aims to become a global leader in precision medicine for neurodegenerative diseases. the company designs, discovers and develops therapeutic as well as diagnostic products intended to prevent and modify diseases caused by misfolding proteins. ac immune’s two proprietary technology platforms create antibodies, small molecules and vaccines designed to address a broad spectrum of neurodegenerative indications, such as alzheimer’s disease (ad). the company’s pipeline features nine therapeutic and three diagnostic product candidates – with five product candidates currently in clinical trials. the most advanced of these is crenezumab, a humanized anti-amyloid-β monoclonal igg4 antibody that targets monomeric and aggregated forms of amyloid-β, with highest affinity for neurotoxic oligomers. crenezumab is currently in two phase 3 clinical studies for ad, under a global program conducted by the collabor